Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
99053-1 Cells counted.total Num BAL Pt Qn &nbsp; &nbsp; ACTIVE Cells Counted Total [#] in Bronchoalveolar lavage &nbsp; ADD DefinitionDescription &nbsp; &nbsp; # &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 99053-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Total Cells Counted BAL &nbsp; &nbsp; &nbsp; N &nbsp; Bronchial alveolar lavage; Bronchoalveolar lavage; Cell; Cellularity; Cnt; Count; HEMATOLOGY/CELL COUNTS; Non-aggregate; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Total cells; Total Cells Counted; Totl 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {#} &nbsp; &nbsp; &nbsp; 0
99054-9 Manual differential comment Imp BAL Pt Nar &nbsp; &nbsp; ACTIVE Manual differential comment [Interpretation] in Bronchoalveolar lavage Narrative &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 99054-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Manual dif comment BAL-Imp &nbsp; &nbsp; &nbsp; N &nbsp; Bronchial alveolar lavage; Bronchoalveolar lavage; cmmt; cmnt; Com; Comm; Comments; Commt; Diff; Differl; Differn; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Manual dif comment; Narrative; Point in time; Random; Remarks; Report 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99055-6 Cardiovascular disease 10Y risk Likelihood ^Patient Pt Qn &nbsp; &nbsp; ACTIVE Cardiovascular disease 10Y risk [Likelihood] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CARD.RISK &nbsp; 99055-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CVD 10Y risk Qn &nbsp; &nbsp; &nbsp; N &nbsp; CARD.RISK; Cardiology; CVD; CVD 10Y risk; Dis; Diseases; Dz; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
99056-4 Cardiovascular disease 10Y risk Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Cardiovascular disease 10Y risk &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CARD.RISK &nbsp; 99056-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CVD 10Y risk &nbsp; &nbsp; &nbsp; N &nbsp; CARD.RISK; Cardiology; CVD; CVD 10Y risk; Dis; Diseases; Dz; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99057-2 SLC12A1 gene full mutation analysis Find Bld Pt Doc Molgen &nbsp; ACTIVE SLC12A1 gene full mutation analysis in Blood by Molecular genetics method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH.MUT &nbsp; 99057-2 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 SLC12A1 Full Mut Anl Bld &nbsp; &nbsp; &nbsp; N &nbsp; Blood; BSC1 gene; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; NKCC2 gene; PCR; Point in time; Random; sequencing of entire coding region; WB; Whole blood 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99058-0 DHCR7 gene full mutation analysis Find Bld/Tiss Pt Doc Sequencing &nbsp; ACTIVE DHCR7 gene full mutation analysis in Blood or Tissue by Sequencing &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH.MUT &nbsp; 99058-0 &nbsp; Sequencing &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DHCR7 gene Full Mut Anl Bld/T Seq &nbsp; &nbsp; &nbsp; N &nbsp; 7-dehydrocholesterol reductase; 7-DHC reductase; Blood; D7SR; delta-7-dehydrocholesterol reductase; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Putative sterol reductase SR-2; Random; sequencing of entire coding region; SLOS; Smith-Lemli-Opitz syndrome; Sterol Delta(7)-reductase; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99059-8 n-Acetylglycine/Creatinine MRto Urine Pt Qn &nbsp; &nbsp; ACTIVE N-acetylglycine/Creatinine [Mass Ratio] in Urine &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/g creatinine &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99059-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 N-acetylglycine/Creat Ur &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/g{creat} &nbsp; &nbsp; &nbsp; 0
9906-9 P wave duration.lead III Time Heart Pt Qn EKG &nbsp; ACTIVE P wave duration in lead III &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ms &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9906-9 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave dur L-III &nbsp; &nbsp; &nbsp; Y &nbsp; 3; Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P wave dur L-III; Painter's colic; PB; Plumbism; Point in time; P-wave interval; QNT; Quan; Quant; Quantitative; Random 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ms &nbsp; &nbsp; &nbsp; 0
99060-6 Cerebroventricular lining cells/Leukocytes NFr CSF Pt Qn &nbsp; &nbsp; ACTIVE Cerebroventricular lining cells/Leukocytes in Cerebral spinal fluid &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 99060-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cerebrov Lin Cell NFr CSF &nbsp; &nbsp; &nbsp; N &nbsp; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cerebrov Lin Cell; Ependymal cells; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells 2.79 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
99061-4 Cholesterol.esterified actual/normal RelACnc Fibroblasts Pt Qn &nbsp; &nbsp; ACTIVE Cholesterol.esterified actual/normal in Fibroblast &nbsp; ADD DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99061-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Esterified Cholest Act/Nor Fib &nbsp; &nbsp; &nbsp; N &nbsp; Act/Nor; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Control; Esterif; Esterified Cholest; Fib; Fibr; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
99062-2 Acetylcholine receptor modulation Ab PrThr Ser Pt Ord Flow cytometry &nbsp; ACTIVE Acetylcholine receptor modulation Ab [Presence] in Serum by Flow cytometry (FC) &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99062-2 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 AChR Mod Ab Ser Ql FC &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Acetylch; ACH; AChR; AChR Mod; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99063-0 Free water clearance VRat Urine+Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Free water Clearance in Urine and Serum or Plasma &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mL/min &nbsp; &nbsp; Free water clearance = Urinary flow rate[1 - (urine osmolality/plasma osmolality)] &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99063-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Free H2O Ur+SerPl-vRate &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Flow; FR; Free H2O; Free H2O clearance; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Volume rate; vRate 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mL/min &nbsp; &nbsp; &nbsp; 0
99064-8 Programmed cell death ligand 1 by clone SP263 Find Tiss Pt Doc &nbsp; &nbsp; ACTIVE PD-L1 by clone SP263 in Tissue Document &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PATH &nbsp; 99064-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 PD-L1 by SP263 Tiss Doc &nbsp; &nbsp; &nbsp; N &nbsp; B7 homolog 1; B7-H1; CD274; Cluster of differentiation 274; Document; Finding; Findings; i; Oncology; PATHOLOGY; PDL1; PD-L1; PD-L1 by SP263; Point in time; Random; Tissue; Tissue, unspecified 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99065-5 Ej Ab ACnc Ser Pt Qn Line blot &nbsp; ACTIVE Ej Ab [Units/volume] in Serum by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99065-5 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ej Ab Ser Line blot-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CADM; Clinically amyopathic DM; Dermatomyositis, Adult Type; Glycyl tRNA synthetase; Point in time; Polymyositis, Idiopathic; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; Release 2.81: COMPONENT: Fixed casing on component; 0
99066-3 PL-12 Ab ACnc Ser Pt Qn Line blot &nbsp; ACTIVE PL-12 Ab [Units/volume] in Serum by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99066-3 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 PL12 Ab Ser Line blot-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Alanyl tRNA Synthetase; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CADM; Clinically amyopathic DM; ILD; Interstitial Lung Disease; PL12; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
99067-1 PL-7 Ab ACnc Ser Pt Qn Line blot &nbsp; ACTIVE PL-7 Ab [Units/volume] in Serum by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99067-1 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 PL7 Ab Ser Line blot-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CADM; Clinically amyopathic DM; Dermatomyositis, Adult Type; PL7; Point in time; Polymyositis, Idiopathic; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; Serum; SR; Threonyl tRNA Synthetase 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
99068-9 Ku Ab ACnc Ser Pt Qn Line blot &nbsp; ACTIVE Ku Ab [Units/volume] in Serum by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99068-9 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ku Ab Ser Line blot-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
99069-7 Jo-1 extractable nuclear Ab ACnc Ser Pt Qn Line blot &nbsp; ACTIVE Jo-1 extractable nuclear Ab [Units/volume] in Serum by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99069-7 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 ENA Jo1 Ab Ser Line blot-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA Jo1; Histidyl-tRNA synthease; i; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
9907-7 P wave duration.lead V1 Time Heart Pt Qn EKG &nbsp; ACTIVE P wave duration in lead V1 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ms &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9907-7 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave dur L-V1 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P wave dur L-V1; Painter's colic; PB; Plumbism; Point in time; P-wave interval; QNT; Quan; Quant; Quantitative; Random 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ms &nbsp; &nbsp; &nbsp; 0
99070-5 Kelch-like protein 11 Ab.IgG Titr Ser Pt SemiQn IF &nbsp; ACTIVE Kelch-like protein 11 IgG Ab [Titer] in Serum by Immunofluorescence &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; <1:240 &nbsp; &nbsp; &nbsp; SERO &nbsp; 99070-5 &nbsp; IF &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 KLHL11 IgG Titr Ser IF &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; KLHL11; Neuro; Neurology; Oncology; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
99071-3 Kelch-like protein 11 Ab.IgG Titr CSF Pt SemiQn IF &nbsp; ACTIVE Kelch-like protein 11 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99071-3 &nbsp; IF &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 KLHL11 IgG Titr CSF IF &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; KLHL11; Neuro; Neurology; Oncology; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
99072-1 Kelch-like protein 11 Ab.IgG PrThr Ser Pt Ord CBA IFA &nbsp; ACTIVE Kelch-like protein 11 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99072-1 &nbsp; CBA IFA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 KLHL11 IgG Ser Ql CBA IFA &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; KLHL11; Neuro; Neurology; Oncology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99073-9 Kelch-like protein 11 Ab.IgG PrThr CSF Pt Ord CBA IFA &nbsp; ACTIVE Kelch-like protein 11 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99073-9 &nbsp; CBA IFA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 KLHL11 IgG CSF Ql CBA IFA &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; KLHL11; Neuro; Neurology; Oncology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99074-7 Calcium/Creatinine MRto Urine^Fetus Pt Qn &nbsp; &nbsp; ACTIVE Calcium/Creatinine [Mass Ratio] in Urine from Fetus &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/mg creatinine &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99074-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Calcium/Creat Ur Fetus &nbsp; &nbsp; &nbsp; N &nbsp; Ca; Cal; Chemistry; CR; Crea; Creat; Fetal; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/mg{creat} &nbsp; &nbsp; &nbsp; 0
99075-4 Alpha-1-Microglobulin/Creatinine MRto Urine 24H Qn &nbsp; &nbsp; ACTIVE Alpha-1-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/g creatinine &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99075-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 A1 Microglob/Creat 24h Ur &nbsp; &nbsp; &nbsp; N &nbsp; 1 day; 24 hours; 24HR; A1; A1 Microglob; A1M; Alfa; Alpha-1-Microglycoprotein; Chemistry; CR; Crea; Creat; HC; i; Mass concentration ratio; Mass ratio; MCRto; Microglob; Protein Human Complex; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/g{creat} &nbsp; &nbsp; &nbsp; 0
108,248 results found